Risk of end-stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT

JAMA

Volumn 278, Issue 23, 1997, Pages 2069-2074

  Brancati, Frederick L ^a,d   Whelton, Paul K ^a   Randall, Bryan L ^b   Neaton, James D ^b   Stamler, Jeremiah ^c   Klag, Michael J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

EID: 0031445530     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.23.2069     Document Type: Article

References (37)

1. US Renal Data System. USRDS 1995 Annual Data Report. Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; April 1995:25-38.
2. Perneger TV, Brancati FL, Whelton PK, Klag MJ. Studying the causes of kidney disease in man: a review of methodologic obstacles and possible solutions. Am J Kidney Dis. 1995;25:722-731.
3. Krolewski M, Eggers PW, Warram JH. Magnitude of end-stage renal disease in IDDM: a 35-year follow-up study. Kidney Int. 1996;50:2041-2046.
4. Humphrey LL, Ballard DJ, Frohnert P, Chu C-P, O'Fallon M, Palumbo PJ. Chronic renal failure in non-insulin-dependent diabetes mellitus. Ann Intern Med. 1989;111:788-796.
5. Lee ET, Lee VS, Lu M, Lee JS, Russell D, Yeh J. Incidence of renal failure in NIDDM: the Oklahoma Indian Diabetes Study. Diabetes. 1994;43:572-579.
6. Nelson RG, Newman JM, Knowler WC, et al. Incidence of end-stage renal disease in type 2 (noninsulin-dependent) diabetes mellitus in Pima Indians. Diabetologia. 1988;31:730-736.
7. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality. JAMA. 1982;248:1465-1477.
8. Multiple Risk Factor Intervention Trial Research Group. Design considerations in the NHLBI Multiple Risk Factor Intervention Trial (MRFIT). J Chronic Dis. 1977;30:261-275.
9. Neaton JD, Grimm RH, Cutler J. Recruitment of participants for the Multiple Risk Factor Intervention Trail (MRFIT). Control Clin Trials. 1988;8:415-535.
10. Sherwin R, Kaelber CT, Kexdi P, Kjelsberg MO, Thomas HE. The Multiple Risk Factor Intervention Trial (MRFIT), II: the development of the protocol. Prev Med. 1981;10:402-425.
11. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993; 16:434-444.
12. Dischinger P, DuChene AG. Quality control aspects of blood pressure measurements in the Multiple Risk Factor Intervention Trial. Control Clin Trials. 1986;7:137S-157S.
13. National Heart and Lung Institute. Manual of Laboratory Operations: Lipid Research Clinical Program. Washington, DC: US Government Printing Office; 1974. DHEW publication NIH 75-628.
14. Klag MJ, Whelton PK, Randall BL, et al. A prospective study of blood pressure and incidence of end-stage renal disease in 332,544 men. N Engl J Med. 1996;334:13-18.
15. Health Care Financing Administration. Research Report: End Stage Renal Disease, 1985. Washington, DC: US Government Printing Office; 1987. HCFA publication 03274.
16. Wentworth DN, Neaton JD, Rasmussen WL. An evaluation of the Social Security Administration MBR file and the National Death Index in the ascertainment of vital status. Am J Public Health. 1983;73:1270-1274.
17. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1988.
18. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
19. Cox DR. Regression models and life tables. J R Stat Soc Ser. 1972;34:187-220.
20. Rostand SG, Kirk KA, Rutsky EA, Pate BA. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med. 1982;306: 1276-1279.
21. Eggers PW, Connerton R, McMullon M. Medicare experience with end-stage renal disease: trends in incidence, prevalence, and survival. Health Care Financing Rev. 1984;5:69-88.
22. Sugimoto T, Rosansky SJ. The incidence of treated end stage renal disease in the eastern United States: 1973-1979. Am J Public Health. 1984;74:14-17.
23. Weller JM, Wu S-CH, Ferguson CW, Hawthorne VM. End-stage renal disease in Michigan. Am J Nephrol. 1985;5:84-95.
24. Kappel DF, Tuien MV. Trends in the incidence of treated end-stage renal disease secondary to diabetic nephropathy: 1973-1981. Am J Kidney Dis. 1986;8:234-238.
25. Pasinski R, Pasinski M. End-stage renal disease among the Zuni Indians: 1973-1983. Arch Intern Med. 1987;147:1093-1096.
26. Megill DM, Hoy WE, Woodruff SD. Rates and causes of end-stage renal disease in Navajo Indians, 1971-1985. West J Med. 1988;149:178-182.
27. Pugh JA, Stern MP, Haffner SM, Eifler CW, Zapata M. Excess incidence of treatment of end-stage renal disease in Mexican Americans. Am J Epidemiol. 1988;127:135-144.
28. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med. 1989;321:1074-1079.
29. Stephens GW, Gillaspy JA, Clyne D, Mejia A, Pollak VE. Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus. Am J Kidney Dis. 1990;15:562-567.
30. Newman JM, Marfin AA, Eggers PW, Helgerson SD. End stage renal disease among Native Americans, 1983-86. Am J Public Health. 1990;80: 318-319.
31. Centers for Disease Control and Prevention. Incidence of treatment for end-stage renal disease attributed to diabetes mellitus, by race/ethnicity -Colorado, 1982-1989. MMWA Morb Mortal Wkly Rep. 1992;41:845-848.
32. Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ. The excess incidence of diabetic end-stage renal disease among blacks: a population-based study of potential explanatory factors. JAMA. 1992;268:3079-3084.
33. Dyck RF, Tan L. Rates and outcomes of diabetic end-stage renal disease among registered native people in Saskatchewan. Can Med Assoc J. 1994; 150:203-208.
34. Nelson RG, Knowler WC, Pettit DJ, Bennett PH. Kidney diseases in diabetes. In: Diabetes in America. 2nd ed. Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease; 1995:349-400. NIH publication 95-1468.
35. Kenny SJ, Aubert RE, Geiss LS. Prevalence and incidence of non-insulin-dependent diabetes. In: Diabetes in America. 2nd ed. Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease; 1995:47-60. NIH publication 95-1468.
36. Fertig BJ, Simmons DA, Martin DB. Therapy for diabetes. In: Diabetes in America. 2nd ed. Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease; 1995:519-523. NIH publication 95-1468.
37. Perneger TV, Whelton PK, Klag MJ, Rossiter KA. Diagnosis of hypertensive end-stage renal disease: effect of patient's race. Am J Epidemiol. 1995; 141:10-15.